Cidara Therapeutics Announces Closing of Public Offering of Common Stock, Including Exercise of Underwriter’s Option to Purchase Additional Shares
13 oct. 2016 09h20 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, Oct. 13, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the closing...
Cidara Therapeutics Announces Commencement of Public Offering of Common Stock
06 oct. 2016 16h01 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, Oct. 06, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that it has...
Cidara Therapeutics to Present at the Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology
20 sept. 2016 16h05 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, Sept. 20, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
Cidara Reports Second Quarter 2016 Financial Results and Provides Corporate Update
11 août 2016 16h12 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, Aug. 11, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
Cidara Therapeutics to Present at the Cantor Fitzgerald Annual Healthcare Conference
06 juil. 2016 07h00 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, July 06, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
Cidara Therapeutics Expands Management Team
05 juil. 2016 07h00 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, July 05, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
Cidara Therapeutics to Present at the Jefferies 2016 Healthcare Conference
02 juin 2016 08h00 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, June 02, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
Cidara Therapeutics to Present at the Needham & Company 15th Annual Healthcare Conference
05 avr. 2016 07h30 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, April 05, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
Cidara Therapeutics Announces Positive Data From Phase 1 Clinical Trial of CD101 IV and Reports Third Quarter 2015 Financial Results
16 nov. 2015 16h13 HE
|
Cidara Therapeutics, Inc.
-- Single Ascending Dose Study-Results Demonstrate Excellent Safety and Tolerability and Support Once-Weekly IV Dosing --
-- Management to Host Webcast and Conference Call Tomorrow at 8:00 a.m. ET...
Cidara Therapeutics to Present at the Jefferies 2015 Global Healthcare Conference in London
10 nov. 2015 07h30 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other infections,...